We are delighted to announce that Dr Felix Agakov has joined Wanda Health as Head of AI.
Dr Agakov, an expert in machine learning for digital health and precision medicine, brings a wealth of knowledge and experience to our team. He holds a PhD in machine learning with a specialization in variational inference and information theory. His work has gained recognition, with features in media outlets like the BBC, CNN Money, The Times, and The Wall Street Journal.
In addition to his academic achievements, Dr Agakov is an accomplished entrepreneur, having co-founded two companies. He has also collaborated with industry leaders such as Intel, Pfizer, and Boehringer Ingelheim, contributing to projects spanning from intelligent compilers to diagnostics for diabetes-related complications.
Furthermore, Dr Agakov has played integral roles in various European and national collaborations, particularly in the field of machine learning for precision medicine and long-term conditions. His leadership as a principal investigator and vice coordinator in projects like MIMOmics and AiCOPD underscores his expertise in statistics and machine learning.
Dr Agakov's research interests are at the forefront of AI development, focusing on data efficiency, multi-task learning, and AI-powered interventions for long-term conditions. He is currently leading various projects, including the development of an AI-based intervention for Chronic Obstructive Pulmonary Disease (COPD), early prediction of diabetes complications, domain-agnostic medical information retrieval, and summary-level transfer learning for co-morbidities.
We eagerly anticipate the valuable contributions he will make to our team and the broader healthcare landscape. Read more about our remote patient monitoring solutions.